rs45527543
Positions:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_015404.4(WHRN):āc.33C>Gā(p.Ser11Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00155 in 1,495,928 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.0013 ( 0 hom., cov: 34)
Exomes š: 0.0016 ( 4 hom. )
Consequence
WHRN
NM_015404.4 missense
NM_015404.4 missense
Scores
3
4
12
Clinical Significance
Conservation
PhyloP100: 3.63
Genes affected
WHRN (HGNC:16361): (whirlin) This gene is thought to function in the organization and stabilization of sterocilia elongation and actin cystoskeletal assembly, based on studies of the related mouse gene. Mutations in this gene have been associated with autosomal recessive non-syndromic deafness and Usher Syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0064022243).
BP6
Variant 9-114504769-G-C is Benign according to our data. Variant chr9-114504769-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 45677.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Benign=1, Uncertain_significance=5}. Variant chr9-114504769-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00129 (197/152296) while in subpopulation NFE AF= 0.00199 (135/68006). AF 95% confidence interval is 0.00171. There are 0 homozygotes in gnomad4. There are 95 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WHRN | NM_015404.4 | c.33C>G | p.Ser11Arg | missense_variant | 1/12 | ENST00000362057.4 | NP_056219.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WHRN | ENST00000362057.4 | c.33C>G | p.Ser11Arg | missense_variant | 1/12 | 1 | NM_015404.4 | ENSP00000354623 | P1 | |
WHRN | ENST00000374057.3 | c.33C>G | p.Ser11Arg | missense_variant | 1/2 | 2 | ENSP00000363170 | |||
WHRN | ENST00000673697.1 | c.33C>G | p.Ser11Arg | missense_variant | 2/2 | ENSP00000501152 |
Frequencies
GnomAD3 genomes AF: 0.00129 AC: 197AN: 152188Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
197
AN:
152188
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00111 AC: 101AN: 90864Hom.: 0 AF XY: 0.00107 AC XY: 55AN XY: 51210
GnomAD3 exomes
AF:
AC:
101
AN:
90864
Hom.:
AF XY:
AC XY:
55
AN XY:
51210
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00158 AC: 2123AN: 1343632Hom.: 4 Cov.: 34 AF XY: 0.00150 AC XY: 994AN XY: 662574
GnomAD4 exome
AF:
AC:
2123
AN:
1343632
Hom.:
Cov.:
34
AF XY:
AC XY:
994
AN XY:
662574
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00129 AC: 197AN: 152296Hom.: 0 Cov.: 34 AF XY: 0.00128 AC XY: 95AN XY: 74478
GnomAD4 genome
AF:
AC:
197
AN:
152296
Hom.:
Cov.:
34
AF XY:
AC XY:
95
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
34
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:3Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 01, 2022 | The p.Ser11Arg variant (rs45527543) has been previously reported in a patient with a clinical diagnosis of Usher Syndrome II (Bonnet 2011). However, the patient reported in Bonnet et al (2011) carried no other relevant variants in the WHRN gene, but did harbor two pathogenic variants in ADGRV1 in a trans heterozygous configuration. This variant is listed in the Genome Aggregation Database (gnomAD) browser with a frequency in Ashkenazi Jewish populations of 0.37% (identified in 21 out of 5,650 chromosomes), and is listed in the ClinVar database with conflicting interpretations of pathogenicity (Variation ID: 45677). The serine at codon 11 is moderately conserved considering 12 species (Alamut software v2.9), and computational analyses suggest this variant has/does not have a significant effect on WHRN protein structure/function (SIFT: tolerated, PolyPhen2: benign, and Mutation Taster: polymorphism). However, based on the available information, the clinical significance of the p.Ser11Arg variant cannot be determined with certainty. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 08, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 30, 2022 | See Variant Classification Assertion Criteria. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Autosomal recessive nonsyndromic hearing loss 31 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Usher syndrome type 2D Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 17, 2015 | p.Ser11Arg in exon 1 of DFNB31 variant is not expected to have clinical signific ance because it has been identified in 0.5% (10/1860) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP r s45527543). In addition, computational prediction tools and conservation data su ggest the variant may not impact the protein. - |
Retinitis pigmentosa-deafness syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
MutationTaster
Benign
N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Pathogenic
D;D
Sift4G
Uncertain
D;D
Polyphen
B;B
Vest4
MutPred
Loss of phosphorylation at S11 (P = 0.0172);Loss of phosphorylation at S11 (P = 0.0172);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at